Sentence examples for compensatory declines from inspiring English sources

Acquiring incidence data for age groups older than those screened allowed us to evaluate any compensatory declines in incidence among previously screened women.

We consider it unlikely that longer follow-up would change these findings, as we were also unable to demonstrate important compensatory declines in countries with longer follow up than Denmark [ 10].

The increase in hydrophobic Leu residues accompanied a compensatory decline in other hydrophobic residues.

Nevertheless, events such as chronic stress raise BACE1 activity and increase sAPPβ levels with a compensatory decline in sAPPα.

Compensatory decline could also be due to the factors associated with chronic upregulation of the proteolytic systems such as component exhaustion or even a direct negative impact of the metabolic changes on the proteolytic systems.

The fact that there is very little compensatory decline in incidence when women are no longer screened, in Norway as well as in other countries (Jørgensen and Gøtzsche, 2009), proves that model-based lead-time models are seriously misleading.

Such long lead times are expected for overdiagnosed tumours, because the compensatory decline in incidence when women are no longer screened owing to advanced age is very small or absent (Jørgensen and Gøtzsche, 2009; Zahl and Mæhlen, 2012).

We then subtracted the compensatory decline in older, previously screened women (ages 70-79 years) to estimate overdiagnosis, after calculating the absolute number of diagnoses that the incidence rates corresponded to.

Despite using data when the compensatory decline was largest (rather than from the last observation year), this adjustment only changed the estimate of overdiagnosis for invasive breast cancer from 35%to31%1%.

Therefore, one possible explanation is that the σ1R deficiency reduces the release of dopamine via the suppression of NMDAr leading to the compensatory decline in the expression of DAT.

Third, we can study whether there is a compensatory decline in the incidence rate when women are no longer invited to screening (Zahl et al, 2004; Jørgensen and Gøtzsche, 2009; Zahl and Mæhlen, 2012).